Stimulation modes for disordered breathing therapy
An implantable system with adaptive nerve stimulation adjusts to respiratory changes, effectively managing disordered breathing by coordinating phrenic and upper-airway nerve stimulation to improve breathing patterns and reduce apnea events.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- ZOLL MEDICAL CORPORATION
- Filing Date
- 2025-12-05
- Publication Date
- 2026-06-25
AI Technical Summary
Existing treatments for disordered breathing, such as sleep apnea, are inadequate in effectively managing respiratory reductions and transitions between different breathing states.
An implantable treatment system with principal and subordinate stimulation circuitry for phrenic and upper-airway nerve electrical stimulation, controlled by an IPG, dynamically adjusts stimulation modes based on respiration sensor feedback to address respiratory reductions.
The system effectively manages respiratory reductions by coordinating phrenic and upper-airway nerve stimulation, improving breathing patterns and reducing apnea events through adaptive control strategies.
Smart Images

Figure US2025058288_25062026_PF_FP_ABST